Advertisement
Singapore markets closed

  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     

  • Bitcoin USD

    63,748.38
    -706.88 (-1.10%)
     

  • CMC Crypto 200

    1,327.51
    -69.02 (-4.94%)
     

  • S&P 500

    5,099.96
    +51.54 (+1.02%)
     

  • Dow

    38,239.66
    +153.86 (+0.40%)
     

  • Nasdaq

    15,927.90
    +316.14 (+2.03%)
     

  • Gold

    2,349.60
    +7.10 (+0.30%)
     

  • Crude Oil

    83.66
    +0.09 (+0.11%)
     

  • 10-Yr Bond

    4.6690
    -0.0370 (-0.79%)
     

  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     

  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Novartis hopes to commercialise "smart lens" within 5 years

Reuters

ZURICH (Reuters) - Novartis (NOVN.VX) expects the "smart lens" technology it has licensed from Google (GOOGL.O) will take several years to develop, but hopes to have a product ready for market in about five years, the drugmaker's chief executive said on Tuesday.

"This isn't going to happen overnight because it's a breakthrough technology. It's not months, we're probably talking about years. We would hope to be able to commercialise within about five years," Joe Jimenez told Reuters in an interview.

Novartis said earlier on Tuesday it had struck an agreement with Google (GOOGL.O) to develop "smart lens" technology for medical use in the eye.

(Reporting by Caroline Copley and Paul Arnold.)